EVKEEZA
EVKEEZA (evinacumab-dgnb) is a monoclonal antibody therapy used to treat patients with homozygous familial hypercholesterolemia (HoFH) — a rare genetic condition that causes extremely high cholesterol levels from birth. EVKEEZA works by inhibiting angiopoietin-like 3 (ANGPTL3), a protein that affects lipid metabolism, helping lower LDL-C (bad cholesterol) levels in patients who do not adequately respond to standard treatments.
Each single-dose, preservative-free vial contains a sterile solution for intravenous infusion, administered by a licensed healthcare provider in a clinical or infusion setting.
InfusionMed USA, based in Carrollton, Texas, provides EVKEEZA and other advanced infusion biologics to specialty clinics, hospitals, and infusion centers throughout Dallas, Plano, Frisco, McKinney, Lewisville, The Colony, and surrounding North Texas communities. We maintain cold-chain integrity, verified sourcing, and prompt delivery for all specialty medications.
For use by healthcare professionals only. Store refrigerated at 2°C–8°C (36°F–46°F). Do not freeze.
Download Form